Top

Published in:

01-08-2020 | Sarcopenia | Thoracic Oncology

Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis

Published in: Annals of Surgical Oncology | Issue 8/2020

Abstract

Background

This meta-analysis aimed to investigate the value of preoperative sarcopenia in predicting complications after esophagectomy. Clinicopathologic characteristics of sarcopenia patients, which may support sarcopenia management, also were studied.

Methods

This study searched for articles describing an association between sarcopenia and short-term outcomes after esophagectomy using PubMed, EMBASE, and the Cochrane Library. Mantel–Haenszel and inverse variance models were used for the meta-analyses of end points.

Results

The meta-analysis included 14 studies comprising a total of 2387 patients. Sarcopenia was significantly associated with advanced age (weighted mean difference [WMD], 3.48; 95% confidence interval [CI], 2.22–4.74), lower body mass index (WMD − 2.22; 95% CI − 2.65 to − 1.79), squamous cell carcinoma (odds ratio [OR], 2.78; 95% CI 1.72–4.47), advanced clinical tumor stage (OR 1.65; 95% CI 1.28–2.15), and neoadjuvant therapy (OR 1.87; 95% CI 1.38–2.53). The sarcopenia patients showed lower preoperative albumin levels (WMD − 0.11; 95% CI − 0.19 to − 0.04) than the nonsarcopenia patients. Sarcopenia was significantly predictive of pneumonia (OR 2.58; 95% CI 1.75–3.81) and overall complications (OR 1.52; 95% CI 1.07–2.15) after esophagectomy. The sarcopenia patients also showed nonsignificant increases in the risks of anastomotic leakage (OR 1.29; 95% CI 0.99–1.67), vocal cord palsy (OR 2.03; 95% CI 0.89–4.64), and major complications (≥ Clavien-Dindo grade III; OR 1.30; 95% CI 0.95–1.79) but not increased operation time, blood loss, or mortality.

Conclusions

Preoperative sarcopenia assessment showed considerable potential for predicting postoperative complications for esophageal cancer patients. To realize this potential, more effective diagnostic criteria and severity classifications for sarcopenia are warranted.

Available only for authorised users

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. https://doi.org/10.1093/ageing/afq034.CrossRefPubMedPubMedCentral

Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia, and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29:154–9. https://doi.org/10.1016/j.clnu.2009.12.004.CrossRefPubMed

Oguma J, Ozawa S, Kazuno A, Yamamoto M, Ninomiya Y, Yatabe K. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(7). https://doi.org/10.1093/dote/doy104.

Jarvinen T, Ilonen I, Kauppi J, Salo J, Rasanen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol. 2018;16:27. https://doi.org/10.1186/s12957-018-1327-4.CrossRefPubMedPubMedCentral

Nakashima Y, Saeki H, Nakanishi R, et al. Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg. 2018;267:1100–4. https://doi.org/10.1097/SLA.0000000000002252.CrossRefPubMed

Saeki H, Nakashima Y, Kudou K, et al. Neoadjuvant chemoradiotherapy for patients with cT3/nearly T4 esophageal cancer: is sarcopenia correlated with postoperative complications and prognosis? World J Surg. 2018;42:2894–901. https://doi.org/10.1007/s00268-018-4554-5.CrossRefPubMed

Siegal SR, Dolan JP, Dewey EN, et al. Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancer. Am J Surg. 2018;215:813–7. https://doi.org/10.1016/j.amjsurg.2017.12.017.CrossRefPubMed

Soma D, Kawamura YI, Yamashita S, et al. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. Dis Esophagus. 2018;32(3). https://doi.org/10.1093/dote/doy092.

Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266:822–30. https://doi.org/10.1097/SLA.0000000000002398.CrossRefPubMed

10.

Nishigori T, Okabe H, Tanaka E, Tsunoda S, Hisamori S, Sakai Y. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol. 2016;113:678–84. https://doi.org/10.1002/jso.24214.CrossRefPubMed

11.

Grotenhuis BA, Shapiro J, van Adrichem S, et al. Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer. World J Surg. 2016;40:2698–704. https://doi.org/10.1007/s00268-016-3603-1.CrossRefPubMedPubMedCentral

12.

Harada K, Ida S, Baba Y, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2016;29:627–33. https://doi.org/10.1111/dote.12381.CrossRefPubMed

13.

Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2016;43:478–84. https://doi.org/10.1016/j.ejso.2016.11.015.CrossRefPubMed

14.

Makiura D, Ono R, Inoue J, et al. Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: a retrospective cohort study. J Geriatr Oncol. 2016;7:430–6. https://doi.org/10.1016/j.jgo.2016.07.003.CrossRefPubMed

15.

Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol. 2015;22:4432–7. https://doi.org/10.1245/s10434-015-4559-3).CrossRefPubMed

16.

Sato S, Nagai E, Taki Y, et al. Hand grip strength as a predictor of postoperative complications in esophageal cancer patients undergoing esophagectomy. Esophagus. 2017;15:10–18. https://doi.org/10.1007/s10388-017-0587-3.CrossRefPubMed

17.

Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017;4:492–8. https://doi.org/10.1002/ehf2.12237.CrossRefPubMedPubMedCentral

18.

Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47. https://doi.org/10.1200/jco.2012.45.2722.CrossRefPubMed

19.

Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2018;31(8). https://doi.org/10.1093/dote/doy047.

20.

Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286–94. https://doi.org/10.1097/SLA.0000000000001098.CrossRefPubMed

21.

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805. https://doi.org/10.1177/0962280216669183.CrossRefPubMed

22.

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. https://doi.org/10.1186/1471-2288-14-135.CrossRefPubMedPubMedCentral

23.

Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35. https://doi.org/10.1016/S1470-2045(08)70153-0.CrossRef

24.

Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. https://doi.org/10.1016/j.jamda.2013.11.025.CrossRefPubMed

25.

Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82:53–9. https://doi.org/10.1093/ajcn.82.1.53.CrossRefPubMed

26.

Wang P, Li Y, Sun H, et al. Predictive value of body mass index for short-term outcomes of patients with esophageal cancer after esophagectomy: a meta-analysis. Ann Surg Oncol. 2019;26:2090–103. https://doi.org/10.1245/s10434-019-07331-w.CrossRefPubMed

27.

Yassaie SS, Keane C, French SJH, Al-Herz FAJ, Young MK, Gordon AC. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection. ANZ J Surg. 2019;89:515–9. https://doi.org/10.1111/ans.15106.CrossRefPubMed

28.

Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19:5598–606. https://doi.org/10.3748/wjg.v19.i34.5598.CrossRefPubMedPubMedCentral

Title: Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis
Publication date: 01-08-2020
Keywords: Sarcopenia
Esophagus Resection
Esophagus Resection
Published in: Annals of Surgical Oncology / Issue 8/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-020-08236-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2020

Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors

ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies

Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

ASO Author Reflections: Discordant Pathologic and Radiologic Response of Colorectal Liver Metastases After Chemotherapy: Which One Should We Trust to Predict Outcome and to Tailor Postoperative Chemotherapy?

In Search of the Optimal Outcome Measure for Patients with Advanced Cancer and Gastrointestinal Obstruction: A Qualitative Research Study

Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation